These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38940720)

  • 1. Predictive factors of mortality in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a novel prognostic scoring system.
    Polat G; Özdemir Ö; Ermin S; Serçe Unat D; Demirci Üçsular F
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Jun; 41(2):e2024021. PubMed ID: 38940720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema.
    Gürün Kaya A; Özyürek BA; Şahin Özdemirel T; Öz M; Erdoğan Y
    Med Princ Pract; 2021; 30(2):154-159. PubMed ID: 32841950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
    He X; Ji J; Liu C; Luo Z; Tang J; Yan H; Guo L
    Ann Med; 2024 Dec; 56(1):2311845. PubMed ID: 38301276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-long term prognosis prediction for idiopathic pulmonary fibrosis patients based on quantitative analysis of fibrotic lung volume.
    Du K; Zhu Y; Mao R; Qu Y; Cui B; Ma Y; Zhang X; Chen Z
    Respir Res; 2022 Dec; 23(1):372. PubMed ID: 36550474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: A cohort study in Taiwan.
    Tseng CM; Chen MY; Kao CY; Tao CW
    J Chin Med Assoc; 2022 May; 85(5):578-583. PubMed ID: 35353790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.
    Karampitsakos T; Torrisi S; Antoniou K; Manali E; Korbila I; Papaioannou O; Sampsonas F; Katsaras M; Vasarmidi E; Papakosta D; Domvri K; Fouka E; Organtzis I; Daniil Z; Dimeas I; Kirgou P; Gourgoulianis KI; Papanikolaou IC; Markopoulou K; Kounti G; Tsapakidou E; Papadopoulou E; Tatsis K; Gogali A; Kostikas K; Tzilas V; Chrysikos S; Papiris S; Bouros D; Kreuter M; Tzouvelekis A
    Respir Res; 2021 May; 22(1):140. PubMed ID: 33952261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease.
    Niitsu T; Fukushima K; Komukai S; Takata S; Abe Y; Nii T; Kuge T; Iwakoshi S; Shiroyama T; Miyake K; Tujino K; Tanizaki S; Iwahori K; Hirata H; Miki K; Yanagawa M; Takeuchi N; Takeda Y; Kida H; Kumanogoh A
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
    Sangani R; Ghio A; Culp S; Patel Z; Sharma S
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1873-1885. PubMed ID: 34188464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone.
    Lacedonia D; Correale M; Tricarico L; Scioscia G; Stornelli SR; Simone F; Casparrini M; Brunetti ND; Foschino Barbaro MP
    Intern Emerg Med; 2022 Apr; 17(3):815-822. PubMed ID: 34787802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust.
    Casillo V; Cerri S; Ciervo A; Stendardo M; Manzoli L; Flacco ME; Manno M; Bocchino M; Luppi F; Boschetto P
    BMC Pulm Med; 2019 Sep; 19(1):170. PubMed ID: 31488107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The St. George's Respiratory Questionnaire as a prognostic factor in IPF.
    Furukawa T; Taniguchi H; Ando M; Kondoh Y; Kataoka K; Nishiyama O; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    Respir Res; 2017 Jan; 18(1):18. PubMed ID: 28095852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
    Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis.
    Mikolasch TA; George PM; Sahota J; Nancarrow T; Barratt SL; Woodhead FA; Kouranos V; Cope VSA; Creamer AW; Fidan S; Ganeshan B; Hoy L; Mackintosh JA; Shortman R; Duckworth A; Fallon J; Garthwaite H; Heightman M; Adamali HI; Lines S; Win T; Wollerton R; Renzoni EA; Steward M; Wells AU; Gibbons M; Groves AM; Gooptu B; Scotton CJ; Porter JC
    EClinicalMedicine; 2023 Jan; 55():101758. PubMed ID: 36483266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
    Huang Y; Ma SF; Vij R; Oldham JM; Herazo-Maya J; Broderick SM; Strek ME; White SR; Hogarth DK; Sandbo NK; Lussier YA; Gibson KF; Kaminski N; Garcia JG; Noth I
    BMC Pulm Med; 2015 Nov; 15():147. PubMed ID: 26589497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.
    Karampitsakos T; Spagnolo P; Mogulkoc N; Wuyts WA; Tomassetti S; Bendstrup E; Molina-Molina M; Manali ED; Unat ÖS; Bonella F; Kahn N; Kolilekas L; Rosi E; Gori L; Ravaglia C; Poletti V; Daniil Z; Prior TS; Papanikolaou IC; Aso S; Tryfon S; Papakosta D; Tzilas V; Balestro E; Papiris S; Antoniou K; Bouros D; Wells A; Kreuter M; Tzouvelekis A
    Respirology; 2023 Jan; 28(1):56-65. PubMed ID: 36117239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors of early death after lung transplantation in patients with idiopathic pulmonary fibrosis complicated with pulmonary arterial hypertension].
    Hu C; Liu M; Yu H; Wang J; Li X; Yue B; Huang D; Hu C; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Feb; 35(2):124-129. PubMed ID: 36916370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
    Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
    Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis.
    Sakamoto S; Shimizu H; Isshiki T; Nakamura Y; Usui Y; Kurosaki A; Isobe K; Takai Y; Homma S
    Sci Rep; 2022 Jan; 12(1):1134. PubMed ID: 35064161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of angiogenin in predicting the prognosis of patients with idiopathic pulmonary fibrosis].
    Bai Y; Zhu H; Sun Q; Gu G; Zhang L; Li Y; Yang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):789-793. PubMed ID: 28936953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.